Uterine papillary serous carcinoma: What have we learned over the past quarter century?

被引：32

作者：

Goff, BA ^{[1
]}

机构：

[1] Univ Washington, Sch Med, Div Gynecol Oncol, Seattle, WA 98195 USA

来源：

GYNECOLOGIC ONCOLOGY | 2005年 / 98卷 / 03期

关键词：

D O I：

10.1016/j.ygyno.2005.07.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：341 / 343

页数：3

共 17 条

[11]

KELLYMG, 2004, GYNECOL ONCOL, V95, P469

[12]

LAUCHLAN SC, 1981, ARCH PATHOL LAB MED, V105, P615

[13]

LOW JS, 2002, GYNECOL ONCOL, V97, P171

[14]

OLIVA E, 2004, AM SOC CLIN ONCOLOGY, P303

[15] Uterine papillary serous carcinomas: the exigency for clinical trials [J].

Podratz, KC ;

Mariani, A .

GYNECOLOGIC ONCOLOGY, 2003, 91 (03) :461-462

[16]

RANDALL ME, AM SOC CLIN ONCOLOGY, P309

[17] Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy [J].

Turner, BC ;

Knisely, JPS ;

Kacinski, BM ;

Haffty, BG ;

Gumbs, AA ;

Roberts, KB ;

Frank, AH ;

Peschel, RE ;

Rutherford, TJ ;

Edraki, B ;

Kohorn, EI ;

Chambers, SK ;

Schwartz, PE ;

Wilson, LD .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (01) :77-84

← 1 2 →